Table 2.

In vitro susceptibilities to fluconazole, itraconazole, and BMS-207147 of bloodstream isolates of Candida spp. from 1997 and 1998

Species (no. of isolates tested) and antifungal agentMIC (μg/ml)% Rc
C. albicans (341)
C. glabrata(106)
C. parapsilosis (97)
C. tropicalis(49)
C. guilliermondii (10)
C. krusei (10)
 Total (613)
  • a 50%, MIC50.

  • b 90%, MIC90.

  • c Based on NCCLS breakpoints (7). All C. krusei isolates are considered fluconazole R.